Winkelmann, A.; Reisinger, E.C.; Boden, K.; Metze, C.; Zettl, U.K.; Loebermann, M.
Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study. Vaccines 2025, 13, 451.
https://doi.org/10.3390/vaccines13050451
AMA Style
Winkelmann A, Reisinger EC, Boden K, Metze C, Zettl UK, Loebermann M.
Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study. Vaccines. 2025; 13(5):451.
https://doi.org/10.3390/vaccines13050451
Chicago/Turabian Style
Winkelmann, Alexander, Emil C. Reisinger, Katharina Boden, Christoph Metze, Uwe K. Zettl, and Micha Loebermann.
2025. "Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study" Vaccines 13, no. 5: 451.
https://doi.org/10.3390/vaccines13050451
APA Style
Winkelmann, A., Reisinger, E. C., Boden, K., Metze, C., Zettl, U. K., & Loebermann, M.
(2025). Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study. Vaccines, 13(5), 451.
https://doi.org/10.3390/vaccines13050451
